Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Organogenesis Holdings Inc 85 Dan Road Canton MA 02021 USA

P: 781-575-0775 F: 781-575-1570

Description:

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

Key Statistics

Overview:

Market Capitalization, $K 340,379
Enterprise Value, $K 296,619
Shares Outstanding, K 130,915
Annual Sales, $ 468,060 K
Annual Net Income, $ 94,900 K
Last Quarter Sales, $ 116,860 K
Last Quarter Net Income, $ 220 K
60-Month Beta 1.65
% of Insider Shareholders 34.40%
% of Institutional Shareholders 44.55%
Float, K 85,880
% Float 65.60%
Short Volume Ratio 0.49

Growth:

1-Year Return -74.40%
3-Year Return -45.92%
5-Year Return -73.50%
5-Year Revenue Growth 237.39%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 11/09/22
Next Earnings Date N/A
Earnings Per Share ttm 0.55
EPS Growth vs. Prev Qtr -55.56%
EPS Growth vs. Prev Year -55.56%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ORGO Ratios

Ratio
Price/Earnings ttm 4.78
Price/Earnings forward 20.23
Price/Earnings to Growth N/A
Return-on-Equity % 28.74%
Return-on-Assets % 15.96%
Profit Margin % 20.28
Net Margin % N/A
Debt/Equity 0.27
Price/Sales 0.74
Price/Cash Flow 2.87
Price/Book 1.34
Book Value/Share 1.96
Interest Coverage 9.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar